Azimilide tegravir (MK-0518) Ciraparantag (free base)

Ciraparantag (free base)

inhibits the activation of isolated primary mouse quiescent hepatic stellate cells (HSCs) and promotes cell death in culture-activated HSCs

Lafutidine (0

Solubility: DMSO: 10 mg/mL(25

Sacubitril/Valsartan: Updates and Clinical Evidence for a Disease-Modifying Approach

Azimilide tegravir (MK-0518) Ciraparantag (free base)Azimilide, also known as NE 10064, a potassium channel blocker potentially for the treatment of arrhythmia. Azimilide has been studied for its anti arrhythmic effects: its converts and maintains sinus rhythm in patients with atrial arrhythmias; and it reduces the frequency and severity of ventricular arrhythmias in patients with implanted cardioverter defibrillators. Azimilide's most important adverse effect is torsades de pointes, which is a form of